0001217455-17-000005.txt : 20170328
0001217455-17-000005.hdr.sgml : 20170328
20170328173127
ACCESSION NUMBER: 0001217455-17-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170324
FILED AS OF DATE: 20170328
DATE AS OF CHANGE: 20170328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forest City Realty Trust, Inc.
CENTRAL INDEX KEY: 0001647509
STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798]
IRS NUMBER: 474113168
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TERMINAL TOWER, 50 PUBLIC SQUARE
STREET 2: SUITE 1100
CITY: CLEVELAND
STATE: OH
ZIP: 44113
BUSINESS PHONE: (216) 621-6060
MAIL ADDRESS:
STREET 1: TERMINAL TOWER, 50 PUBLIC SQUARE
STREET 2: SUITE 1100
CITY: CLEVELAND
STATE: OH
ZIP: 44113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Brien Robert G.
CENTRAL INDEX KEY: 0001217455
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37671
FILM NUMBER: 17719991
MAIL ADDRESS:
STREET 1: 50 PUBLIC SQUARE SUITE 1100
CITY: CLEVELAND
STATE: OH
ZIP: 44113
FORMER NAME:
FORMER CONFORMED NAME: OBRIEN ROBERT G
DATE OF NAME CHANGE: 20030205
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-03-24
0001647509
Forest City Realty Trust, Inc.
FCEA/FCEB
0001217455
O'Brien Robert G.
50 PUBLIC SQUARE, SUITE 1100
CLEVELAND
OH
44113
0
1
0
0
Exec VP & CFO
Class A Common Stock
71581
I
See footnote
Class A Common Stock
24148
D
Class A Common Stock
17018
D
Class A Common Stock
16301
D
Class A Common Stock
10745
D
Class A Common Stock
12537
I
See footnote
Class A Common Stock
12553
I
See footnote
Class A Common Stock
12553
I
See footnote
Class A Common Stock
216736
D
Class A Common Stock
2017-03-24
4
A
0
13353
0
A
13353
D
2008 Stock Option Grant (right to buy)
36.38
2010-06-18
2018-06-18
Class A Common
28059
28059
D
2009 Stock Option Grant (right to buy)
7.80
2011-04-21
2019-04-21
Class A Common
7011
7011
D
2010 Stock Option Grant (right to buy)
15.89
2012-04-14
2020-04-14
Class A Common
26893
26893
D
2011 Stock Option Grant (right to buy)
17.72
2013-04-13
2021-04-13
Class A Common
38547
38547
D
2012 Stock Option Grant (right to buy)
14.74
2014-04-11
2022-04-11
Class A Common
39694
39694
D
2013 Stock Option Grant (right to buy)
17.60
2015-04-08
2023-04-08
Class A Common
33422
33422
D
2014 Stock Option Grant (right to buy)
18.73
2016-03-28
2024-03-28
Class A Common
31620
31620
D
2014 Performance Shares
0
2017-12-31
1988-08-08
Class A Common
19576
19576
D
2015 Performance Shares
0
2017-12-31
1988-08-08
Class A Common
15339
15339
D
2016 Performance Shares
0
2018-12-31
1988-08-08
Class A Common
21489
21489
D
2017 Performance Shares
0
2017-03-24
4
A
0
20029
0
A
2019-12-31
1988-08-08
Class A Common
20029
20029
D
2015 Out Performance Shares
0
2017-12-31
1988-08-08
Class A Common
40000
40000
D
Robert G. O'Brien Trust - account with Schwab .
2013 Restricted Stock Grant - 25% vest on 4/08/2015; 25% vest on 4/08/2016; and 50% vest on 4/08/2017.
2014 Restricted Stock Grant - 0% vest on 3/28/2015; 25% vest on 3/28/2016; 25% vest on 3/28/2017; and 50% vest on 3/28/2018.
2015 Restricted Stock Grant - 25% vest on 3/26/2016; 25% vest on 3/26/2017; and 50% vest on 3/26/2018.
2016 Restricted Stock Grant - 25% vest on 3/23/2017; 25% vest on 3/23/2018; and 50% vest on 3/23/2019.
2017 Restricted Stock Grant - 25% vest on 3/24/2018; 25% vest on 3/24/2019; and 50% vest on 3/24/2020.
Shares held by Robert L. O'Brien, son - Indirect
Shares held by Kathleen G. O'Brien, daughter - Indirect
Shares held by Sara F. O'Brien, daughter - Indirect
Shares are held by Robert & Ann (wife) O'Brien in a street account at Commonwealth. 3,581 restricted shares vested on 3/23/2017, of those 1,195 shares were returned to the Company to cover taxes, the balance of the shares were moved to this account. 8,150 restricted shares vested on 3/26/2017, of those 2,836 shares were returned to the Company to cover taxes, the balance of the shares were moved to this account.
2008 Stock Option Grant - 25% exercisable 6/18/2010; 25% exercisable 6/18/2011; and 50% exercisable 6/18/2012.
2009 Stock Option Grant - 25% exercisable 4/21/2011; 25% exercisable 4/21/2012; and 50% exercisable 4/21/2013.
2010 Stock Option Grant - 25% exercisable 4/14/2012; 25% exercisable 4/14/2013; and 50% exercisable 4/14/2014.
2011 Stock Option Grant - 25% exercisable 4/13/2013; 25% exercisable 4/13/2014; and 50% exercisable 4/13/2015.
2012 Stock Option Grant - 25% exercisable 4/11/2014; 25% exercisable 4/11/2015; and 50% exercisable 4/11/2016.
2013 Stock Option Grant - 25% exercisable 4/08/2015; 25% exercisable 4/08/2016; and 50% exercisable 4/08/2017.
2014 Stock Option Grant - 0% exercisable 3/28/2015; 25% exercisable 3/28/2016; 25% exercisable 3/28/2017; and 50% exercisable 3/28/2018.
Performance Shares Award - granted 3/28/2014 - performance period is from January 1, 2014 to December 31, 2017. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $18.73 per share. There is no fixed expiration date.
Performance Shares Award - granted 3/26/2015 - performance period is from January 1, 2015 to December 31, 2017. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $24.62 per share. There is no fixed expiration date.
Performance Shares Award - granted 3/23/2016 - performance period is from January 1, 2016 to December 31, 2018. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $20.94 per share. There is no fixed expiration date.
Performance Shares Award - granted 3/24/2017 - performance period is from January 1, 2017 to December 31, 2019. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $21.83 per share. There is no fixed expiration date.
Out Performance Shares Award - granted 3/27/2015 - performance period is from January 1, 2015 to December 31, 2017. Awards will vest 50% on December 31, 2017 and 50% on December 31, 2018 and will be available to the grantee provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 300% of the number of Performance Shares granted. Fair market value on date of grant is $25.31 per share. There is no fixed expiration date.
Original filing erroneously did not show the vested shares moving to the street account; the filing was amended to correct total number of unvested shares and the correct number of shares held in the street account. Footnotes to the original filing explaining the vestings and account movements were correct.
J. Matthew Shady, Attorney-In-Fact for Robert G. O'Brien
2017-03-28
EX-24
2
poa-robrien.txt
POWER OF ATTORNEY
SEC FORMS 4 & 5
POWER OF ATTORNEY
The undersigned, designated by the Board of Directors as a Section 16
Company Insider, hereby constitutes and appoints Gerayln M. Presti,
J. Matthew Shady and Patricia A. Comai, with full power of substitution
and resubstitution, as attorney of the undersigned, their name, place
and stead, to sign and file under the Securities Exchange Act of 1934,
Section 16 Reporting Forms, any and all amendments and apply for EDGAR
Access Codes as required thereto, to be filed with the Securities and
Exchange Commission pertaining to such filing, with full power and
authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, hereby ratifying
and approving the act of said attorney and any such substitute.
EFFECTIVE as of March 1, 2013.
By: \s\ Robert G. O'Brien
Robert G. O'Brien